- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
XOLAIR - 150mg - 1 x 2ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R03DX05 | BioTech | Omalizumab - 150mg | 5194 | 23729/06 | XOLAIR | 150mg | 1 x 2ml | Injectable lyophilised powder for solution+diluent | SC | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 50,309,160 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |